Topic prioritisation
Showing 1 to 2 of 2
| Title | Prioritisation routing | Decision | Decision date |
|---|---|---|---|
| Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [TSID11969] | None selected | Not selected | |
| MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270) | None selected | Not selected |